" /> Aluminum Hydroxide Adjuvanted Multi-epitope SARS-CoV-2 Vaccine - CISMeF





Preferred Label : Aluminum Hydroxide Adjuvanted Multi-epitope SARS-CoV-2 Vaccine;

NCIt definition : A vaccine composed of chemically synthesized peptides of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epitopes, conjugated to a recombinant carrier protein, and adsorbed on aluminum hydroxide, with potential immunomodulating and anti-COVID-19 activities. Upon administration of aluminum hydroxide adjuvanted multi-epitope SARS-CoV-2 vaccine, the SARS-CoV-2 peptides activate the immune system to produce antibodies and T-cell responses against these SARS-CoV-2 peptides. This kills SARS-CoV-2 and prevents SARS-CoV-2 infection. The aluminum hydroxide adjuvant improves antigen processing by the immune system.;

Drug name : EpiVacCorona;

NCI Metathesaurus CUI : CL1661226;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.